Astria Therapeutics Inc (ATXS) stock news · $382.1M cap
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
This ATXS news page leads with what Astria Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ATXS yet. We will not pad this page with generic market recap.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ATXS stock page; for the tape open the quote page.
ATXS stock news FAQ
What are ATXS's latest revenue and net income?
Latest cached Astria Therapeutics Inc (ATXS) revenue for Sep 30, 2025 was $706.0K. Net income was -$98.4M. Statements: https://lician.com/financials/atxs
What is ATXS's market cap?
Astria Therapeutics Inc (ATXS) market cap is $382.1M on the latest cached fundamentals snapshot.
What kind of company is ATXS?
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Where is ATXS stock news listed?
Cached stock news for Astria Therapeutics Inc (ATXS) is listed at https://lician.com/news/atxs. Filings: https://lician.com/sec/atxs
Not investment advice.